Author: Agbontaen, Kaladerhan Osemwengie; Somasundram, Khevan; Baker, Matthew
Title: Critical COVID-19 in a 24-week pregnant woman with 32 days of invasive mechanical ventilation before delivery of fetus: a case of successful collaborative multidisciplinary care Cord-id: nv9iosr9 Document date: 2021_9_8
ID: nv9iosr9
Snippet: We describe the successful treatment of a 24-week pregnant, 44-year-old woman with COVID-19. Management of this complex case required multidisciplinary collaboration and included prolonged invasive mechanical ventilation and prone positioning. Caesarean section delivery was delayed for 32 days, with no monitored fetal compromise, while stabilising the mother. To our knowledge, this is the longest reported duration of invasive ventilation while pregnant in a patient with COVID-19. COVID-19 has be
Document: We describe the successful treatment of a 24-week pregnant, 44-year-old woman with COVID-19. Management of this complex case required multidisciplinary collaboration and included prolonged invasive mechanical ventilation and prone positioning. Caesarean section delivery was delayed for 32 days, with no monitored fetal compromise, while stabilising the mother. To our knowledge, this is the longest reported duration of invasive ventilation while pregnant in a patient with COVID-19. COVID-19 has been shown to cause increased disease severity in pregnant women, and certain pregnancy-related physiological adaptations that occur could help explain this association. While COVID-19 has been shown to cause no increased adverse neonatal outcomes, clinicians should be aware that data show increased preterm birth in symptomatic pregnant women, thereby increasing the chance of prematurity-related complications. Further research on COVID-19 in pregnancy is crucial to facilitate better management, and full inclusion of pregnant women in therapeutic clinical trials will help achieve this.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and additional study: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and admission indication: 1
- acute ards respiratory distress syndrome and lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and lobe consolidation: 1
- acute ards respiratory distress syndrome and low lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome treatment and additional study: 1
- acute respiratory distress syndrome and additional consolidation: 1
- acute respiratory distress syndrome and additional study: 1, 2, 3, 4, 5, 6, 7
- acute respiratory distress syndrome and admission indication: 1, 2
- acute respiratory distress syndrome and lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute respiratory distress syndrome and lobe consolidation: 1, 2
- acute respiratory distress syndrome and low lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute respiratory syndrome and additional consolidation: 1
- acute respiratory syndrome and additional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and admission indication: 1, 2, 3, 4
- acute respiratory syndrome and lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute respiratory syndrome and lmwh therapy: 1
- acute respiratory syndrome and lobe consolidation: 1, 2, 3, 4, 5
- acute respiratory syndrome and low lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
Co phrase search for related documents, hyperlinks ordered by date